Dr Lane recorded that he proposed to the CBLA Scientific and Technical Committee in the spring of 1981 that a research project into the development of coagulation factor concentrates with reduced risk of hepatitis transmission was an appropriate project for central funding.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Richard S Lane